About
Date: 3 May 2018
Time: 17:30 - 20:00
Venue: CAB lecture theatre, Clifford Allbutt Building, Biomedical Campus, University of Cambridge, CB2 0AH
This meeting will highlight a range of perspectives and contributions to the development of new therapeutics.Cambridge New Therapeutics Forum events are open to all scientists researching new therapeutics in Cambridge and the local area.
Programme
17:30 – Arrival, Registration, Tea & Coffee
18:00 – Welcome
18:10 – Prof David Rubinsztein, FMedSci FRS, CIMR Deputy Director, Professor of Molecular Neurogenetics, Wellcome Trust Principal Research Fellow, Honorary Consultant in Medical Genetics
Autophagy, a guardian against neurodegeneration
18:25 – Dr Rebecca Taylor, Research Leader, MRC LMB
Investigating the Neuronal Roles of XBP1
18:40 – Dr Mark Halliday, MRC Toxicology Unit, Career Development Fellow
Repurposing drugs to treat neurodegeneration
19:10 – Networking and Refreshments
20:00 – Meeting close
Meeting attendance is free but all attendees must register in advance. Spaces are limited, so early registration is encouraged to avoid disappointment.
Click here to book your place.